嘧啶-2-羧酸盐酸盐 | 433214-15-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 嘧啶-2-羧酸盐酸盐
• 英文名称: 2-pyrimidinecarboxylic acid hydrochloride
• 英文别名: Pyrimidine-2-carboxylic acid hydrochloride；pyrimidine-2-carboxylic acid;hydrochloride
• CAS: 433214-15-4
• 化学式: C₅H₄N₂O₂*ClH
• mdl: MFCD19382250
• 分子量: 160.56
• InChiKey: GPKJPVULGYVDQA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.67
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.1
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  嘧啶-2-羧酸盐酸盐 在 氯化亚砜 作用下， 以 氯仿 为溶剂， 以0.306 g (67%)的产率得到2-嘧啶羰酰氯
  参考文献：
  名称：

  1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring

  摘要：

  本发明涉及在苯环的位置2处取代的新型1-(N-苯基氨基烷基)哌嗪衍生物。还考虑包括本发明化合物的药物组合物。本发明化合物还被考虑用于治疗哺乳动物下尿路神经肌肉功能障碍。

  公开号：

  US06399614B1

文献信息

• [EN] HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR<br/>[FR] COMPOSÉ AMIDE HETEROCYCLIQUE ET UTILISATION DE CELUI-CI EN TANT QU'INHIBITEUR MMP-13
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005105760A1

  公开（公告）日：2005-11-10

  The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen-containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), - - - is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionnally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X’ is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-5,6-dimethyl-4-oxo-1,4-dihadrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.

  本发明提供了一种新型酰胺衍生物，具有基质金属蛋白酶抑制活性，并且作为药用剂是有用的，该化合物由以下式(I)表示，其中环A是一个可选择取代的含氮杂环，环B是一个可选择取代的单环同核环或可选择取代的单环杂环，Z是N或NR1（R1是氢原子或可选择取代的碳氢基团），- - - 是一个单键或双键，R2是氢原子或可选择取代的碳氢基团，X是具有1到6个原子的可选择取代的间隔物，环C是(1)一个可选择取代的同核环或(2)除了由(II)表示的环之外的可选择取代的杂环（X'是S、O、SO或CH2），并且环B和环C中至少有一个具有取代基，但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]-2-羟基丙基}-5,6-二甲基-4-氧代-1,4-二氢噻吩[2,3-d]嘧啶-2-羧酰胺或其盐。
• MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN
  申请人：VERSEON CORPORATION

  公开号：US20170326125A1

  公开（公告）日：2017-11-16

  There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.

  提供了用于抑制凝血酶的多取代芳香化合物，其中化合物包括取代的吡唑基或取代的三唑基。此外还提供了药物组合物。此外还提供了治疗和预防疾病或紊乱的方法，该疾病或紊乱可通过抑制凝血酶进行治疗或预防。
• MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS
  申请人：VERSEON CORPORATION

  公开号：US20160024047A1

  公开（公告）日：2016-01-28

  There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of kallikrein, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of kallikrein.

  本发明提供了多取代芳香化合物，其中包括取代的吡唑基或取代的三唑基，用于抑制卡利肽酶，另外还提供了制药组合物。本发明还提供了治疗和预防某些疾病或疾病的方法，该疾病或疾病可通过抑制卡利肽酶来治疗或预防。
• Multisubstituted aromatic compounds as serine protease inhibitors
  申请人：VERSEON CORPORATION

  公开号：US10058541B2

  公开（公告）日：2018-08-28

  There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of kallikrein, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of kallikrein.

  除其他外，还提供了可用于抑制卡利克林的多取代芳香族化合物，这些化合物包括取代的吡唑基或取代的三唑基。另外还提供了药物组合物。此外，还提供了治疗和预防某些疾病或失调的方法，这些疾病或失调可通过抑制卡利克林来治疗或预防。
• Multisubstituted aromatic compounds as inhibitors of thrombin
  申请人：VERSEON CORPORATION

  公开号：US10653674B2

  公开（公告）日：2020-05-19

  There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.

  除其他外，还提供了可用于抑制凝血酶的多取代芳香族化合物，这些化合物包括取代的吡唑基或取代的三唑基。此外，还提供了药物组合物。另外还提供了治疗和预防疾病或紊乱的方法，这种疾病或紊乱可通过抑制凝血酶来治疗或预防。